ropinirole has been researched along with apomorphine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Allerton, CM; Batchelor, DV; Baxter, AD; Blagg, J; Burring, DJ; Carr, CL; Cook, AS; Nichols, CL; Phipps, J; Sanderson, VG; Verrier, H; Wong, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lange, KW | 1 |
| Factor, SA | 1 |
| Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
| Ingvarsson, PE; Johnels, B; Olsson, T; Steg, G | 1 |
| Jankovic, J; Le, WD | 1 |
| Baillet, C; Callizot, N; Guénet, JL; Poindron, P; Warter, JM | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Curry, JT; Humphrey, SJ; Turman, CN; Wheeler, GJ | 1 |
| Andersohn, F; Garbe, E | 1 |
| Fujinami, A; Ikeda, E; Inoue, S; Kuno, S; Ohta, K; Ohta, M | 1 |
| Hiratochi, M; Ijiro, T; Kaidoh, K; Oana, F; Suzuki, T; Tsuchioka, A; Yamauchi, Y | 1 |
| Matute, MS; Matute, R; Merino, P | 1 |
| Johnson, JA; Kirchofer, KS; Rosenstein, NA | 1 |
6 review(s) available for ropinirole and apomorphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of dopamine agonists in Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Ergot Alkaloids; Humans; Indoles; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles | 1998 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Design and Synthesis of Dopaminergic Agonists.
Topics: Apomorphine; Dopamine Agonists; Drug Design; Humans; Indoles; Parkinson Disease; Phenanthridines; Quinolines; Receptors, Dopamine | 2016 |
2 trial(s) available for ropinirole and apomorphine
| Article | Year |
|---|---|
The Posturo-Locomotion-Manual Test. A simple method for the characterization of neurological movement disturbances.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apomorphine; Diagnosis, Differential; Diagnostic Techniques, Neurological; Humans; Indoles; Levodopa; Locomotion; Middle Aged; Parkinson Disease; Posture | 2001 |
Ropinirole has similar efficacy to apomorphine for induction of emesis and removal of foreign and toxic gastric material in dogs.
Topics: Animals; Apomorphine; Dog Diseases; Dogs; Emetics; Foreign Bodies; Ophthalmic Solutions; Vomiting | 2023 |
7 other study(ies) available for ropinirole and apomorphine
| Article | Year |
|---|---|
Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.
Topics: Administration, Intranasal; Animals; Crystallography, X-Ray; Dogs; Dopamine Agonists; Drug Design; Humans; Models, Molecular; Molecular Structure; Rats; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship | 2007 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Electromyography; Female; Genes, Recessive; Immunohistochemistry; Indoles; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Motor Activity; Neurons; Parkinson Disease, Secondary; Postural Balance; Selegiline; Tyrosine 3-Monooxygenase | 2001 |
Cardiovascular and electrocardiographic effects of the dopamine receptor agonists ropinirole, apomorphine, and PNU-142774E in conscious beagle dogs.
Topics: Action Potentials; Animals; Apomorphine; Blood Pressure; Dogs; Dopamine Agonists; Drug Tolerance; Electrocardiography; Female; Heart Rate; Imidazoles; Indoles; Quinolines; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2006 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Astrocytes; Brain-Derived Neurotrophic Factor; Bromocriptine; Cells, Cultured; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Indoles; Mice; Mice, Inbred ICR; Nerve Growth Factor; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2010 |
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions.
Topics: Animals; Antiparkinson Agents; Apomorphine; Azepines; Benzothiazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Ergolines; Indoles; Injections, Intraventricular; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Quinolines; Receptors, Dopamine D2; Tetrahydronaphthalenes; Thiophenes | 2015 |